NL255047A - - Google Patents

Info

Publication number
NL255047A
NL255047A NL255047DA NL255047A NL 255047 A NL255047 A NL 255047A NL 255047D A NL255047D A NL 255047DA NL 255047 A NL255047 A NL 255047A
Authority
NL
Netherlands
Prior art keywords
dextran
benzyl
pharmaceutical product
chloride
substituted
Prior art date
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL255047A publication Critical patent/NL255047A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL255047D 1959-08-21 NL255047A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US835189A US3063905A (en) 1959-08-21 1959-08-21 Carboxy methyl benzyl dextran dextro-amphetamine

Publications (1)

Publication Number Publication Date
NL255047A true NL255047A (da)

Family

ID=25268864

Family Applications (1)

Application Number Title Priority Date Filing Date
NL255047D NL255047A (da) 1959-08-21

Country Status (6)

Country Link
US (1) US3063905A (da)
BE (1) BE594311A (da)
DE (1) DE1177773B (da)
FR (1) FR561M (da)
GB (1) GB904874A (da)
NL (1) NL255047A (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130126A (en) * 1962-09-14 1964-04-21 Central Pharmacal Company Oral pharmaceutical products prepared with carboxymethyl benzyl dextran having a low carboxymethyl d. s. of 0.15
US3130125A (en) * 1962-09-14 1964-04-21 Central Pharmacal Company Preparation of medicated benzyl dextran gradual release therapeutic products containing up to five percent benzyl alcohol
US3242049A (en) * 1963-05-20 1966-03-22 Ncr Co Process for making enterically useful complex of spiramycin and product thereof
US3364111A (en) * 1964-11-20 1968-01-16 Meito Sangyo Kk Carboxymethylated dextran for peptic ulcers
US4260602A (en) * 1977-08-16 1981-04-07 Burroughs Wellcome Co. Hapten polysaccharide conjugate medicaments and method of use
SE445013B (sv) * 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
IT1131833B (it) * 1980-06-20 1986-06-25 Crinos Industria Farmaco Eccipienti per sostanze spermicide
CH658594A5 (de) * 1982-02-22 1986-11-28 Bruss Ni Sanitarno Gigieniches Arzneipraeparat mit antinikotinwirkung und verfahren fuer seine herstellung.
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
US20110076332A1 (en) * 2009-08-27 2011-03-31 Xiaojun Yu Dextran-chitosan based in-situ gelling hydrogels for biomedical applications

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2536168A (en) * 1947-09-29 1951-01-02 Clark & Clark Co Amphetamine chewing gum
US2609368A (en) * 1950-10-21 1952-09-02 Univ Ohio State Res Found Carbohydrate processes
US2749274A (en) * 1952-05-06 1956-06-05 Bristol Lab Inc Stable aqueous procaine penicillin suspension
BE550150A (da) * 1955-08-08
US2811516A (en) * 1955-09-21 1957-10-29 Ohio Commw Eng Co Iodo carboxymethyl dextran and methods of making it
US2885393A (en) * 1956-02-24 1959-05-05 R K Laros Company Dextran-iron complex and process for making same
US2856398A (en) * 1956-06-15 1958-10-14 Ohio Commw Eng Co Carboxymethyl dextran-iron complexes
US2902408A (en) * 1957-09-12 1959-09-01 Organon Suspensions of drugs destined for injection and process for the preparation thereof
US2997423A (en) * 1959-04-20 1961-08-22 Ohio Commw Eng Co Method of making a composition of sodium carboxymethyl dextran and an antibiotic

Also Published As

Publication number Publication date
BE594311A (fr) 1961-02-22
GB904874A (en) 1962-09-05
US3063905A (en) 1962-11-13
FR561M (da) 1961-06-05
DE1177773B (de) 1964-09-10

Similar Documents

Publication Publication Date Title
KR940008030B1 (ko) 이온화가능한 약제용 용매 시스템
EP0185420B1 (en) Dihydrocodeine/ibuprofen pharmaceutical compositions and method
FR561M (da)
US4778799A (en) Synergistic combination of flupirtin and non-steroidal antiphlogistic
US3143465A (en) Pharmaceutical preparations comprising phosphorus containing cation exchange resins having a basic drug adsorbed thereon; and treatment therewith
DE2966564D1 (en) Therapeutic compositions with enhanced bioavailability and process for their preparation
ES8506705A1 (es) Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles
US3784704A (en) Compositions of 4-biphenyl acetic acid and method of use
GB902659A (en) A process for the production of a derivative of thebaine
US2910403A (en) Anti hypertensive compositions comprising 2-methyl-5, 8-dimethoxychromone and acetamides
US3019226A (en) Piperazine salt of phytic acid
ES449062A1 (es) Procedimiento para la preparacion de composiciones farmaceu-ticas que comprenden debricina heterocoloidal.
US3181994A (en) Analgesic biphenyl acetic acid derivatives
US2472453A (en) Streptomycin composition of reduced toxicity
US2224256A (en) Pharmaceutical preparation
US3019166A (en) Antiphlogistic and choleretic compositions and process of therapeutically using same
ES269442A1 (es) Procedimiento de preparaciën de orotato de lisina
US3262847A (en) Calcium salt of dextran for treating cattle delivery paresis
US3644630A (en) Indomethacin suppositories
US2940898A (en) Aluminum salt antacid compositions and method of using same
US2907768A (en) Dihydrohydroxycodeinone derivative
US3298915A (en) Vascular headache treatment
GB808269A (en) Barbiturate pharmaceutical preparations
GB1505849A (en) 9,10-dihydroanthracen-9,10-imine derivatives
IL42201A (en) 2-((1-benzylcyclopentyl)-imino)pyrrolidine